“IMMUNE CHECKPOINT INHIBITOR SALVAGE THERAPY IN PATIENT WITH REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA”, Вопр. онкол., vol. 65, no. 2, pp. 294–297, Feb. 2019, doi: 10.37469/0507-3758-2019-65-2-294-297.